Abstract:Background: X-box-binding protein 1 (XBP1) and N-acetyltransferase 1 (NAT1) are involved in oncogenesis and progression of many human cancer types. However, the roles of XBP1 and NAT1 in gallbladder cancer (GBC) are never reported.Methods: We examined XBP1 and NAT1 expression in GBC and matched adjacent non-tumor tissues via Western blotting. Then, we assayed XBP1 and NAT1 expression in 215 GBCs, including 69 squamous cell/adenosquamous carcinomas (SC/ASCs) and 146 adenocarcinomas (ACs) with immunohistochemistry. Their prognostic and clinicopathological significance was further evaluated using the χ2 test or Fisher's exact test, Kaplan–Meier univariate survival analysis, and log-rank tests.Results: XBP1 expression was upregulated, and NAT1 expression was downregulated in GBC. Immunohistochemical results showed that XBP1 expression was negatively associated with NAT1 expression in GBC, including SC/ASC and AC. The rate of patients with an age of more than 45 years, positivity of lymph node metastasis, and invasion were significantly higher in SC/ASC than those in AC (all P < 0.05). The percentage of XBP1-positive and NAT1-negative expression was significantly higher in the cases with poor differentiation, advanced tumor, nodes, and metastases (TNM) stage, lymph node metastasis, invasion, and only receiving biopsy in GBC, SC/ASC, and AC (all P < 0.05). XBP1-positive and NAT1-negative expression was positively related to larger tumor size (>3 cm) in GBC and AC. There was a negative association between XBP1 and NAT1 expression in GBC, SC/ASC, and AC (all P < 0.05). Positive XBP1 and negative NAT1 expression was closely associated with decreased overall survival in GBC, SC/ASC, and AC patients (all P < 0.05). The multivariate Cox regression analysis showed that positive XBP1 or negative NAT1 expression was an independent factor for poor prognosis in gallbladder SC/ASC and AC patients.Conclusions: This study indicates that positive XBP1 and negative NAT1 expression are closely associated with the clinicopathological and biological behaviors and poor prognosis in GBC.

Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.

Over-expression of Lysine-Specific Demethylase 1 Predicts Tumor Progression and Poor Prognosis in Human Esophageal Cancer.

High Expression of Lysine-Specific Demethylase 1 Correlates with Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma

Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.

LASP-1 Induces Proliferation, Metastasis and Cell Cycle Arrest at the G2/M Phase in Gallbladder Cancer by Down-Regulating S100P Via the PI3K/AKT Pathway

LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.

Tumor Suppressor LKB1 Inhibits the Progression of Gallbladder Carcinoma and Predicts the Prognosis of Patients with This Malignancy

DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.

Over-Expression of Lsd1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer

Upregulation of Long Non-Coding RNA LINC00152 by SP1 Contributes to Gallbladder Cancer Cell Growth and Tumor Metastasis Via PI3K/AKT Pathway.

Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer

Mybl2 is A Potential Prognostic Marker That Promotes Cell Proliferation in Gallbladder Cancer

The Inhibitory Effects of Deleted in Liver Cancer 1 Gene on Gallbladder Cancer Growth Through Induction of Cell Cycle Arrest and Apoptosis

Long Non-Coding RNA LINC01410 Promoted Tumor Progression Via the ErbB Signaling Pathway by Targeting STAT5 in Gallbladder Cancer.

Overexpression of LAPTM4B Promotes Growth of Gallbladder Carcinoma Cells in Vitro

Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness

Expression and clinical significance of lysine specific demethylase 1 in human esophageal squamous cell carcinoma

SPOCK1 As a Potential Cancer Prognostic Marker Promotes the Proliferation and Metastasis of Gallbladder Cancer Cells by Activating the PI3K/AKT Pathway

The Roles of LSD1-mediated Epigenetic Modifications in Maintaining the Pluripotency of Bladder Cancer Stem Cells.

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

Abnormal Inflammatory Status Promotes Lymphatic Metastasis of Gallbladder Cancer Cells Through the CACUL1/NRF2/ITGBL1/ITGA9/VEGF-C Pathway